Abbott Lyon Ltd 08953621 false 2024-04-01 2025-03-31 2025-03-31 2025-03-31 The principal activity of the company is watch and jewellery sales. Digita Accounts Production Advanced 6.30.9574.0 true true true false true 08953621 2024-04-01 2025-03-31 08953621 2025-03-31 08953621 bus:Consolidated 2025-03-31 08953621 core:FurtherSpecificItem1DeferredTaxComponentTotalForDeferredTax 2025-03-31 08953621 core:FurtherSpecificItem2DeferredTaxComponentTotalForDeferredTax 2025-03-31 08953621 core:RetainedEarningsAccumulatedLosses 2025-03-31 08953621 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2025-03-31 08953621 core:ShareCapital 2025-03-31 08953621 core:ShareCapital bus:Consolidated 2025-03-31 08953621 core:SharePremium 2025-03-31 08953621 core:SharePremium bus:Consolidated 2025-03-31 08953621 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2025-03-31 08953621 core:HirePurchaseContracts core:CurrentFinancialInstruments 2025-03-31 08953621 core:HirePurchaseContracts core:CurrentFinancialInstruments bus:Consolidated 2025-03-31 08953621 core:CurrentFinancialInstruments 2025-03-31 08953621 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 08953621 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2025-03-31 08953621 core:Goodwill bus:Consolidated 2025-03-31 08953621 core:OtherResidualIntangibleAssets bus:Consolidated 2025-03-31 08953621 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2025-03-31 08953621 core:BetweenTwoFiveYears 2025-03-31 08953621 core:WithinOneYear 2025-03-31 08953621 core:FurnitureFittingsToolsEquipment bus:Consolidated 2025-03-31 08953621 core:MotorVehicles bus:Consolidated 2025-03-31 08953621 core:OtherPropertyPlantEquipment bus:Consolidated 2025-03-31 08953621 bus:FRS102 bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:Audited bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:FullAccounts bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:RegisteredOffice bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:Director1 2024-04-01 2025-03-31 08953621 bus:Director1 bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:Director2 bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:Director3 bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:Director4 bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:HighestPaidDirector bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:Consolidated 1 2024-04-01 2025-03-31 08953621 bus:PrivateLimitedCompanyLtd bus:Consolidated 2024-04-01 2025-03-31 08953621 bus:ConsolidatedGroupCompanyAccounts 2024-04-01 2025-03-31 08953621 bus:Agent1 bus:Consolidated 2024-04-01 2025-03-31 08953621 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 08953621 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2024-04-01 2025-03-31 08953621 core:ShareCapital 2024-04-01 2025-03-31 08953621 core:ShareCapital bus:Consolidated 2024-04-01 2025-03-31 08953621 core:SharePremium 2024-04-01 2025-03-31 08953621 core:SharePremium bus:Consolidated 2024-04-01 2025-03-31 08953621 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2024-04-01 2025-03-31 08953621 countries:RestWorldOutsideEurope bus:Consolidated 2024-04-01 2025-03-31 08953621 countries:UnitedKingdom bus:Consolidated 2024-04-01 2025-03-31 08953621 core:BrandNames bus:Consolidated 2024-04-01 2025-03-31 08953621 core:CopyrightsPatentsTrademarksServiceOperatingRights bus:Consolidated 2024-04-01 2025-03-31 08953621 core:Goodwill bus:Consolidated 2024-04-01 2025-03-31 08953621 core:OtherResidualIntangibleAssets bus:Consolidated 2024-04-01 2025-03-31 08953621 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2024-04-01 2025-03-31 08953621 core:LandBuildingsUnderOperatingLeases bus:Consolidated 2024-04-01 2025-03-31 08953621 core:FurnitureFittings bus:Consolidated 2024-04-01 2025-03-31 08953621 core:FurnitureFittingsToolsEquipment bus:Consolidated 2024-04-01 2025-03-31 08953621 core:MotorVehicles bus:Consolidated 2024-04-01 2025-03-31 08953621 core:OfficeEquipment bus:Consolidated 2024-04-01 2025-03-31 08953621 core:OtherPropertyPlantEquipment bus:Consolidated 2024-04-01 2025-03-31 08953621 core:Vehicles bus:Consolidated 2024-04-01 2025-03-31 08953621 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-04-01 2025-03-31 08953621 core:UKTax bus:Consolidated 2024-04-01 2025-03-31 08953621 countries:EnglandWales bus:Consolidated 2024-04-01 2025-03-31 08953621 2024-03-31 08953621 bus:Consolidated 2024-03-31 08953621 core:RetainedEarningsAccumulatedLosses 2024-03-31 08953621 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2024-03-31 08953621 core:ShareCapital 2024-03-31 08953621 core:ShareCapital bus:Consolidated 2024-03-31 08953621 core:SharePremium 2024-03-31 08953621 core:SharePremium bus:Consolidated 2024-03-31 08953621 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2024-03-31 08953621 core:Goodwill bus:Consolidated 2024-03-31 08953621 core:OtherResidualIntangibleAssets bus:Consolidated 2024-03-31 08953621 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2024-03-31 08953621 core:FurnitureFittingsToolsEquipment bus:Consolidated 2024-03-31 08953621 core:MotorVehicles bus:Consolidated 2024-03-31 08953621 core:OtherPropertyPlantEquipment bus:Consolidated 2024-03-31 08953621 2023-04-01 2024-03-31 08953621 2024-03-31 08953621 bus:Consolidated 2024-03-31 08953621 core:FurtherSpecificItem1DeferredTaxComponentTotalForDeferredTax 2024-03-31 08953621 core:FurtherSpecificItem2DeferredTaxComponentTotalForDeferredTax 2024-03-31 08953621 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2024-03-31 08953621 core:ShareCapital bus:Consolidated 2024-03-31 08953621 core:SharePremium bus:Consolidated 2024-03-31 08953621 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2024-03-31 08953621 core:HirePurchaseContracts core:CurrentFinancialInstruments 2024-03-31 08953621 core:HirePurchaseContracts core:CurrentFinancialInstruments bus:Consolidated 2024-03-31 08953621 core:CurrentFinancialInstruments 2024-03-31 08953621 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 08953621 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2024-03-31 08953621 core:Goodwill bus:Consolidated 2024-03-31 08953621 core:OtherResidualIntangibleAssets bus:Consolidated 2024-03-31 08953621 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2024-03-31 08953621 core:BetweenTwoFiveYears 2024-03-31 08953621 core:WithinOneYear 2024-03-31 08953621 core:FurnitureFittingsToolsEquipment bus:Consolidated 2024-03-31 08953621 core:MotorVehicles bus:Consolidated 2024-03-31 08953621 core:OtherPropertyPlantEquipment bus:Consolidated 2024-03-31 08953621 bus:HighestPaidDirector bus:Consolidated 2023-04-01 2024-03-31 08953621 bus:Consolidated 2023-04-01 2024-03-31 08953621 bus:Consolidated 1 2023-04-01 2024-03-31 08953621 bus:Consolidated core:PreviouslyStatedAmount 2023-04-01 2024-03-31 08953621 core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 08953621 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2023-04-01 2024-03-31 08953621 core:ShareCapital 2023-04-01 2024-03-31 08953621 core:ShareCapital bus:Consolidated 2023-04-01 2024-03-31 08953621 core:SharePremium 2023-04-01 2024-03-31 08953621 core:SharePremium bus:Consolidated 2023-04-01 2024-03-31 08953621 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2023-04-01 2024-03-31 08953621 countries:RestWorldOutsideEurope bus:Consolidated 2023-04-01 2024-03-31 08953621 countries:UnitedKingdom bus:Consolidated 2023-04-01 2024-03-31 08953621 core:LandBuildingsUnderOperatingLeases bus:Consolidated 2023-04-01 2024-03-31 08953621 core:PreviouslyStatedAmount 2023-04-01 2024-03-31 08953621 core:UKTax bus:Consolidated 2023-04-01 2024-03-31 08953621 2023-03-31 08953621 bus:Consolidated core:PreviouslyStatedAmount 2023-03-31 08953621 core:RetainedEarningsAccumulatedLosses 2023-03-31 08953621 core:RetainedEarningsAccumulatedLosses bus:Consolidated core:PreviouslyStatedAmount 2023-03-31 08953621 core:ShareCapital 2023-03-31 08953621 core:ShareCapital bus:Consolidated core:PreviouslyStatedAmount 2023-03-31 08953621 core:SharePremium 2023-03-31 08953621 core:SharePremium bus:Consolidated core:PreviouslyStatedAmount 2023-03-31 08953621 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated core:PreviouslyStatedAmount 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 08953621

Abbott Lyon Ltd

Annual Report and Consolidated Financial Statements

for the Year Ended 31 March 2025

 

Abbott Lyon Ltd

Contents

Company Information

1

Strategic Report

2

Directors' Report

3

Statement of Directors' Responsibilities

4

Independent Auditor's Report

5 to 7

Consolidated Profit and Loss Account

8

Consolidated Balance Sheet

9

Balance Sheet

10

Consolidated Statement of Changes in Equity

11

Statement of Changes in Equity

12

Consolidated Statement of Cash Flows

13

Notes to the Financial Statements

14 to 25

 

Abbott Lyon Ltd

Company Information

Directors

Jeremy Paul Skelton

Nicholas Ashley Skelton

Gareth Gwynne Jones

Mark James Wasley

Registered office

12 Old Bond Street
Bath
BA1 1BP

Solicitors

RWK Goodman
Midland Bridge House
Midland Bridge Road
Bath
BA2 3FP

Bankers

Lloyds Bank
29 High Street
Chippenham
Wiltshire
SN15 3HA

Auditors

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Abbott Lyon Ltd

Strategic Report for the Year Ended 31 March 2025

The directors present their strategic report for the year ended 31 March 2025.

Principal activity

The principal activity of the group is retail of jewellery, watches and other accessories.

Fair review of the business

The results for the year which are set out in the profit and loss account show turnover of £47,717,034 (2024 - £44,633,250 and an operating profit of £5,361,329 (2024 - £4,862,532). At 31 March 2025 the group had net assets of £9,028,722 (2024 - £7,179,280). The directors consider the performance for the year and the financial position at the year end to be satisfactory.

Key performance indicators

Given the natures of the business, the group's directors are of the opinion that the above key performance indicators are important. The group uses a number of indicators to monitor and improve the development, performance and position of the business. Indicators are reviewed and altered to meet changes in the internal and external environments.

Principal risks and uncertainties

The management of the group and the execution of the group's strategy are subject to a number of risks. The key business risks and uncertainties affecting the group are considered to relate to competition from other jewellery and accessories trades and changes in external factors which influence the cost base, shipping cost and supplies.

Financial instruments

The group enters into forward foreign currency contracts to mitigate the exchange rate risk for certain foreign currency transactions.

Going concern

The group has sufficient financial resources available and is currently trading profitably and generating cash. The directors believe that the group has sufficient resources to continue in operational existence for the foreseeable future and have continued to adopt the going concern basis in preparing the accounts.

In making the current year's assessment the Directors have considered the available cash reserves, profitability and reviewed forecasts.

Approved by the Board on 27 November 2025 and signed on its behalf by:


Jeremy Paul Skelton
Director

 

Abbott Lyon Ltd

Directors' Report for the Year Ended 31 March 2025

The directors present their report and the for the year ended 31 March 2025.

Directors of the company

The directors who held office during the year were as follows:

Jeremy Paul Skelton

Nicholas Ashley Skelton

Gareth Gwynne Jones

Mark James Wasley

Future developments

The external commercial environment was expected to remain competitive during 2025. Actions taken by the Directors has put the group in a good position to continue to react and operate while monitoring the situation.

Disclosure of information to the auditor

Each director has taken the steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditor is unaware.

Principal activities and Business review are discussed in the Strategic Report.

Approved by the Board on 27 November 2025 and signed on its behalf by:


Jeremy Paul Skelton
Director

 

Abbott Lyon Ltd

Statement of Directors' Responsibilities

The directors are responsible for preparing the Strategic Report, Directors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group's and the company's transactions and disclose with reasonable accuracy at any time the financial position of the group and the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Abbott Lyon Ltd

Independent Auditor's Report to the Members of Abbott Lyon Ltd

Opinion

We have audited the financial statements of Abbott Lyon Ltd (the 'parent company') and its subsidiary (the 'group') for the year ended 31 March 2025, which comprise the Consolidated Profit and Loss Account, Consolidated Balance Sheet, Balance Sheet, Consolidated Statement of Changes in Equity, Statement of Changes in Equity, Consolidated Statement of Cash Flows, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the group's and the parent company's affairs as at 31 March 2025 and of the group's profit for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

 

Abbott Lyon Ltd

Independent Auditor's Report to the Members of Abbott Lyon Ltd

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

the parent company financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group’s and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Extent to which the audit was capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We considered the nature of the group's and parent company's industry and its control environment and reviewed the group's and parent company's documentation of their policies and procedures relating to fraud and compliance with laws and regulations. We also enquired of management about their own identification and assessment of the risks of irregularities.

We obtained an understanding of the legal and regulatory framework that the group and parent company operate in and identified the key laws and regulations that had a direct effect on the determination of material
amounts and disclosures in the financial statements, including the UK Companies Act and tax legislation, and, those that do not have a direct effect on the financial statements but compliance with which may be fundamental to the group and parent company ability to operate or to avoid a material penalty.

We discussed among the audit engagement team regarding the opportunities and incentives that may exist within the organisation for fraud and how and where fraud might occur in the financial statements.

In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override of controls. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments; assessed whether the judgments made in accounting estimates are indicative of a potential bias; and evaluated the business rationale of any significant transactions that are unusual or outside the normal course of business.

 

Abbott Lyon Ltd

Independent Auditor's Report to the Members of Abbott Lyon Ltd

In addition to the above, our procedures to respond to the risks identified included the following:

reviewing the financial statement disclosures by testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;

performing analytical procedures to identity any unusual or unexpected relationships that may indicate risks of material misstatements due to fraud;

enquiring of management concerning actual and potential litigation and claims and instances of non-compliance with laws and regulations; and

reading minutes of meetings of those charged with governance.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion. There are inherent limitations in the audit procedures performed and the
further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.




Jenny Staight (Senior Statutory Auditor)
For and on behalf of Hazlewoods LLP, Statutory Auditor

Windsor House
Bayshill Road
Cheltenham
GL50 3AT

28 November 2025

 

Abbott Lyon Ltd

Consolidated Profit and Loss Account for the Year Ended 31 March 2025

Note

2025
£

2024
£

Turnover

3

47,717,034

44,633,250

Cost of sales

 

(33,759,262)

(32,277,835)

Gross profit

 

13,957,772

12,355,415

Administrative expenses

 

(8,596,443)

(7,492,883)

Operating profit

4

5,361,329

4,862,532

Other interest receivable and similar income

5

83,376

5,519

Interest payable and similar expenses

6

(700)

(896)

   

82,676

4,623

Profit before tax

 

5,444,005

4,867,155

Tax on profit

9

(1,594,563)

(1,178,705)

Profit for the financial year

 

3,849,442

3,688,450

Profit/(loss) attributable to:

 

Owners of the company

 

3,849,442

3,688,450

The above results were derived from continuing operations.

The group has no recognised gains or losses for the year other than the results above.

 

Abbott Lyon Ltd

(Registration number: 08953621)
Consolidated Balance Sheet as at 31 March 2025

Note

2025
 £

2024
 £

Fixed assets

 

Intangible assets

10

423,752

267,025

Tangible assets

11

335,094

379,601

 

758,846

646,626

Current assets

 

Stocks

12

2,688,948

2,874,030

Debtors

13

371,163

794,549

Cash at bank and in hand

14

9,784,980

7,133,944

 

12,845,091

10,802,523

Creditors: Amounts falling due within one year

15

(4,451,161)

(4,139,063)

Net current assets

 

8,393,930

6,663,460

Total assets less current liabilities

 

9,152,776

7,310,086

Provisions for liabilities

9

(124,054)

(130,806)

Net assets

 

9,028,722

7,179,280

Capital and reserves

 

Called up share capital

18

1

1

Share premium reserve

18

5,427

5,427

Profit and loss account

9,023,294

7,173,852

Equity attributable to owners of the company

 

9,028,722

7,179,280

Total equity

 

9,028,722

7,179,280

Approved and authorised by the Board on 27 November 2025 and signed on its behalf by:
 

Jeremy Paul Skelton
Director

 

Abbott Lyon Ltd

(Registration number: 08953621)
Company Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

10

423,752

267,025

Tangible assets

11

335,094

379,601

 

758,846

646,626

Current assets

 

Stocks

12

2,651,909

2,874,030

Debtors

13

1,048,533

793,459

Cash at bank and in hand

14

8,869,864

7,037,515

 

12,570,306

10,705,004

Creditors: Amounts falling due within one year

15

(4,203,640)

(4,393,605)

Net current assets

 

8,366,666

6,311,399

Total assets less current liabilities

 

9,125,512

6,958,025

Provisions for liabilities

(124,054)

(130,806)

Net assets

 

9,001,458

6,827,219

Capital and reserves

 

Called up share capital

18

1

1

Share premium reserve

5,427

5,427

Retained earnings

8,996,030

6,821,791

Shareholders' funds

 

9,001,458

6,827,219

The company made a profit after tax for the financial year of £4,174,239 (2024 - profit of £3,470,967).

Approved and authorised by the Board on 27 November 2025 and signed on its behalf by:
 

Jeremy Paul Skelton
Director

 

Abbott Lyon Ltd

Consolidated Statement of Changes in Equity for the Year Ended 31 March 2025
Equity attributable to the parent company

Share capital
£

Share premium
£

Profit and loss account
£

Total
£

At 1 April 2024

1

5,427

7,173,852

7,179,280

Profit for the year

-

-

3,849,442

3,849,442

Dividends

-

-

(2,000,000)

(2,000,000)

At 31 March 2025

1

5,427

9,023,294

9,028,722

Share capital
£

Share premium
£

Profit and loss account
£

Total
£

At 1 April 2023

1

-

3,485,402

3,485,403

Profit for the year

-

-

3,688,450

3,688,450

New share capital subscribed

-

5,427

-

5,427

At 31 March 2024

1

5,427

7,173,852

7,179,280

 

Abbott Lyon Ltd

Company Statement of Changes in Equity for the Year Ended 31 March 2025

Share capital
£

Share premium
£

Profit and loss account
£

Total
£

At 1 April 2024

1

5,427

6,821,791

6,827,219

Profit for the year

-

-

4,174,239

4,174,239

Dividends

-

-

(2,000,000)

(2,000,000)

At 31 March 2025

1

5,427

8,996,030

9,001,458

Share capital
£

Share premium
£

Profit and loss account
£

Total
£

At 1 April 2023

1

-

3,350,824

3,350,825

Profit for the year

-

-

3,470,967

3,470,967

New share capital subscribed

-

5,427

-

5,427

At 31 March 2024

1

5,427

6,821,791

6,827,219

 

Abbott Lyon Ltd

Consolidated Statement of Cash Flows for the Year Ended 31 March 2025

Note

2025
 £

2024
 £

Cash flows from operating activities

Profit for the year

 

3,849,442

3,688,450

Adjustments to cash flows from non-cash items

 

Depreciation and amortisation

4

335,169

251,227

Loss on disposal of tangible assets

-

75,418

Finance income

5

(83,376)

(5,519)

Finance costs

6

700

896

Income tax expense

9

1,594,563

1,178,705

Foreign exchange gains

 

23,073

49,295

 

5,719,571

5,238,472

Working capital adjustments

 

Decrease/(increase) in stocks

12

185,082

(946,675)

Decrease/(increase) in trade debtors

13

423,386

(469,068)

(Decrease)/Increase in trade creditors

15

(45,389)

792,439

Cash generated from operations

 

6,282,650

4,615,168

Corporation taxes paid

9

(1,262,816)

(1,025,000)

Net cash flows from operating activities

 

5,019,834

3,590,168

Cash flows from investing activities

 

Interest received

83,376

5,519

Acquisitions of tangible assets

(164,173)

(479,080)

Acquisitions of intangible assets

10

(283,216)

(243,140)

Net cash flows used in investing activities

 

(364,013)

(716,701)

Cash flows from financing activities

 

Interest paid

 

(700)

(896)

Dividends paid

(2,000,000)

-

Repayment of directors' loan accounts

 

-

(1,512,289)

Repayment of finance lease creditors

 

(4,085)

(4,339)

Proceeds from issuance of new shares

 

-

5,427

Net cash flows used in financing activities

 

(2,004,785)

(1,512,097)

Net increase in cash and cash equivalents

 

2,651,036

1,361,370

Cash and cash equivalents at 1 April 2024

 

7,133,944

5,772,574

Cash and cash equivalents at 31 March 2025

 

9,784,980

7,133,944

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The principal activity of the Company is retail of jewellery, watches and other accessories.

The address of its registered office is:
12 Old Bond Street
Bath
BA1 1BP
England

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Basis of consolidation

The consolidated financial statements consolidate the financial statements of the company and its subsidiary undertakings drawn up to 31 March 2025.

No Profit and Loss Account is presented for the company as permitted by section 408 of the Companies Act 2006.

A subsidiary is an entity controlled by the company. Control is achieved where the company has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities.

Inter-company transactions, balances and unrealised gains on transactions between the company and its subsidiaries, which are related parties, are eliminated in full.

Intra-group losses are also eliminated but may indicate an impairment that requires recognition in the consolidated financial statements.

Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the group. Non-controlling interests in the net assets of consolidated subsidiaries are identified separately from the group’s equity therein. Non-controlling interests consist of the amount of those interests at the date of the original business combination and the non-controlling shareholder’s share of changes in equity since the date of the combination.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Going concern

After reviewing the group's and parent company's forecasts and projections, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. The group and parent company therefore continues to adopt the going concern basis in preparing its financial statements.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the group’s activities. Turnover is shown net of sales/value added tax, returns, refunds and discounts and after eliminating sales within the group

The group recognises revenue when it can be reliably measured, when it is probable that future economic benefits will flow to the entity, and when goods are despatched or delivered to customers.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing on the initial transaction dates.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the group operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements and on unused tax losses or tax credits in the group. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

10%, 20% or 33% on cost

Computer equipment

10% or 33% on cost

Vehicles

33% on cost

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

Intangible assets

Separately acquired trademarks, licences and website development costs are shown at historical cost.

Patents, trademarks, trade licences (including software) and website development cost acquired in a business combination are recognised at fair value at the acquisition date.

Patents, trademarks, licences and website development cost have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Patents, trademarks and licences

10% straight line

Website

33% straight line

Brand

10% to 33% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the group will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the average unit cost method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the group does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the group has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a results of a pat event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the balance sheet and the amount of the provision as an expense.

Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the group’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the group has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

3

Turnover

The analysis of the group's Turnover for the year from continuing operations is as follows:

2025
£

2024
£

Sale of merchandise

47,717,034

44,633,250

The analysis of the group's turnover for the year by market is as follows:

2025
£

2024
£

UK

40,639,946

38,030,622

Rest of world

7,077,088

6,602,628

47,717,034

44,633,250

 

4

Operating profit

Arrived at after charging/(crediting)

2025
£

2024
£

Depreciation expense

208,680

171,264

Amortisation expense

126,489

79,963

Foreign exchange losses

23,088

51,209

Operating lease expense - property

117,934

109,948

Loss on disposal of property, plant and equipment

-

75,418

 

5

Other interest receivable and similar income

2025
£

2024
£

Interest income on bank deposits

83,376

5,519

 

6

Interest payable and similar expenses

2025
£

2024
£

Interest on obligations under finance leases and hire purchase contracts

700

896

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

7

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2025
£

2024
£

Wages and salaries

3,212,478

2,938,199

Social security costs

399,727

334,407

Pension costs, defined contribution scheme

183,810

59,136

3,796,015

3,331,742

The average number of persons employed by the company (including directors) during the year, was 69 (2024 - 65).

 

8

Directors' remuneration

The directors' remuneration for the year was as follows:

2025
£

2024
£

Remuneration

445,836

425,000

Contributions paid to money purchase schemes

28,700

4,800

474,536

429,800

In respect of the highest paid director:

2025
£

2024
£

Remuneration

165,000

165,000

 

9

Taxation

Tax charged/(credited) in the consolidated profit and loss account

2025
£

2024
£

Current taxation

UK corporation tax

1,460,813

1,106,127

UK corporation tax adjustment to prior periods

140,502

(136)

1,601,315

1,105,991

Deferred taxation

Arising from origination and reversal of timing differences

(7,493)

72,714

Arising from previously unrecognised tax loss, tax credit or temporary difference of prior periods

741

-

Total deferred taxation

(6,752)

72,714

Tax expense in the income statement

1,594,563

1,178,705

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

The tax on profit before tax for the year is higher than the standard rate of corporation tax in the UK (2024 - higher than the standard rate of corporation tax in the UK) of 25% (2024 - 25%).

The differences are reconciled below:

2025
£

2024
£

Profit before tax

5,444,005

4,867,155

Corporation tax at standard rate

1,359,202

1,162,418

Increase/(decrease) in UK and foreign current tax from adjustment for prior periods

140,502

(136)

Effect of revenues exempt from taxation

-

(62)

Effect of expense not deductible in determining taxable profit (tax loss)

81,860

16,484

Adjustment to tax charge in respect of previous periods

740

-

Tax increase from other tax effects for reconciliation between accounting profit and tax expense (income)

-

1

Fixed asset differences

12,259

-

Total tax charge

1,594,563

1,178,705

Deferred tax

Company

Deferred tax assets and liabilities

2025

Liability
£

Difference between accumulated depreciation and capital allowances

129,846

Short term timing difference

(5,792)

124,054

2024

Liability
£

Difference between accumulated depreciation and capital allowances

132,770

Short term timing difference

(1,964)

130,806

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

10

Intangible assets

Group

Website
 £

Trademarks, patents and licenses
 £

Other intangible assets
 £

Total
£

Cost or valuation

At 1 April 2024

154,235

2,630

213,058

369,923

Additions acquired separately

87,080

-

196,136

283,216

At 31 March 2025

241,315

2,630

409,194

653,139

Amortisation

At 1 April 2024

61,388

1,931

39,579

102,898

Amortisation charge

62,214

263

64,012

126,489

At 31 March 2025

123,602

2,194

103,591

229,387

Carrying amount

At 31 March 2025

117,713

436

305,603

423,752

At 31 March 2024

92,847

699

173,479

267,025

 

11

Tangible assets

Group and company

Furniture, fittings and equipment
 £

Motor vehicles
 £

Computer equipment
£

Total
£

Cost

At 1 April 2024

151,049

127,603

332,978

611,630

Additions

31,003

-

133,170

164,173

At 31 March 2025

182,052

127,603

466,148

775,803

Depreciation

At 1 April 2024

60,176

28,354

143,499

232,029

Charge for the year

42,793

42,530

123,357

208,680

At 31 March 2025

102,969

70,884

266,856

440,709

Carrying amount

At 31 March 2025

79,083

56,719

199,292

335,094

At 31 March 2024

90,873

99,249

189,479

379,601

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

12

Stocks

 

Group

Company

2025
£

2024
£

2025
£

2024
£

Finished goods

2,688,948

2,874,030

2,651,909

2,874,030

 

13

Debtors

   

Group

Company

Note

2025
£

2024
£

2025
£

2024
£

Trade debtors

 

32,963

3,368

3,061

3,055

Amounts owed by related parties

21

-

-

718,424

-

Prepayments

 

307,437

766,739

296,285

765,962

Receivable from directors

 

30,763

24,442

30,763

24,442

 

371,163

794,549

1,048,533

793,459

 

14

Cash and cash equivalents

 

Group

Company

2025
£

2024
£

2025
£

2024
£

Cash at bank

9,784,980

7,133,944

8,869,864

7,037,515

 

15

Creditors

   

Group

Company

Note

2025
£

2024
£

2025
£

2024
£

Due within one year

 

Loans and borrowings

16

5,874

9,959

5,874

9,959

Trade creditors

 

1,520,380

1,801,368

1,495,119

1,799,565

Amounts due to related parties

21

-

-

-

466,787

Social security and other taxes

 

644,316

604,918

454,989

511,387

Other payables

 

43,668

160,555

43,668

160,555

Accruals

 

1,494,136

1,157,975

1,403,792

1,041,064

Corporation tax liability

9

742,787

404,288

800,198

404,288

 

4,451,161

4,139,063

4,203,640

4,393,605

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

16

Loans and borrowings

Current loans and borrowings

 

Group

Company

2025
£

2024
£

2025
£

2024
£

Hire purchase contracts

5,874

9,959

5,874

9,959

 

17

Pension and other schemes

Defined contribution pension scheme

The group operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the group to the scheme and amounted to £183,810 (2024 - £59,136).

The pension liability as of 31 March 2025 amounted to £19,502 (2024 - £11,420).

 

18

Share capital

Allotted, called up and fully paid shares

 

2025

2024

 

No.

£

No.

£

Ordinary of £0.0001 each

13,074

1.31

13,074

1.31

         

In 2024,there were 3,074 new shares issued during the year at £0.0001 which resulted to £5,427 share premium.

Type of shares

No. of shares

Value

A Shares

8,445

.8445

B Shares

700

.0700

D Shares

25

.0025

E Shares

830

.0830

Growth B1 Shares

1,856

.1856

Growth C1 Shares

225

.0225

Growth D1 Shares

228

.0228

Growth E1 Shares

225

.0225

Growth A2 Shares

230

.0230

Growth B2 Shares

82

.0082

Growth C2 Shares

75

.0075

Growth D2 Shares

78

.0078

Growth E2 Shares

75

.0075

 

13,074

1.3074

 

Abbott Lyon Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

19

Obligations under leases and hire purchase contracts

Company

Operating leases

The total of future minimum lease payments is as follows:

2025
£

2024
£

Not later than one year

31,937

44,303

Later than one year and not later than five years

2,948

14,077

34,885

58,380

The amount of non-cancellable operating lease payments recognised as an expense during the year was £57,544 (2024 - £37,896).

 

20

Dividends

2025
 £

2024
 £

Dividends paid

2,000,000

-

 

21

Related party transactions

Summary of transactions with key management

Key management personnel are considered to be directors of the company and key management personnel remuneration is disclosed in note 8 to the financial statements.